SCOPUS BIOPHARMA INC's ticker is SCPS and the CUSIP is 809171101. A total of 18 filers reported holding SCOPUS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -50.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 5,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -61.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -68.7% | 5,000 | -46.5% | 0.00% | – |
| Q2 2021 | $67,000 | -61.3% | 9,338 | -54.5% | 0.00% | – |
| Q1 2021 | $173,000 | – | 20,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M&R CAPITAL MANAGEMENT INC | 76,819 | $33,000 | 0.01% |
| VANGUARD GROUP INC | 54,649 | $24,000 | 0.00% |
| UBS Group AG | 100 | $0 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,966 | $14,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 4,360 | $2,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 25,800 | $11,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 89 | $0 | 0.00% |
| NORTHERN TRUST CORP | 12,516 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 217,078 | $93,000 | 0.00% |